Truxima®▼

Explore our promotional feature on the biosimilar rituximab, Truxima®. Prescribing information is available on the following page.

Read More

VJHemHeroes: EHA 2018 winners!

We are searching for HemHeroes at EHA 2018! Who is a Hem Hero? We are calling all scientists, doctors, pharmacists,…

Read More

Expert Roundtable Highlights from ASH 2017

In collaboration with the HME Forum, VJHemOnc invites you to view the “LIVE from ATLANTA” broadcast series, featuring expert-led roundtable…

Read More

Overcoming resistance to tyrosine kinase inhibitors

This article aims to provide an understanding of CML disease progression and the current treatment pathway, as well as some…

Read More

BSH 2018 Specialist Nursing Session

Calling all hematology nurses!

Read More

ISAL 2017: Developments in acute leukemias

The International Symposium on Acute Leukemias (ISAL) 2017 was, as always, filled with data, scientific developments and debate. To capture…

Read More

The Evolution of Chemotherapy

Using the A-DAC principle to unlock new treatment options in Hodgkin lymphoma On the 23rd of October, 2016 a panel…

Read More

Biosimiliars

Can the dream of affordable cancer care come true?

Read More
VJHemOnc is intended for Healthcare Professionals only

By choosing to continue, you are confirming that you are a healthcare professional

VJHO needs the contact information you provide to inform you about our latest hemonc news and videos, educational courses and industry supported content (some of which may be promotional in nature). You may unsubscribe from these communications at anytime. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy.

The content of VJHemOnc is intended for healthcare professionals